INS and neoplasm: In case of insufficient compliance with those recommendations, the addition of insulin-sensitizing substances (drugs and/or food supplements) should be applied in the identified subjects in order to counteract the risk of diabetes, cardiovascular diseases, neoplasms, and neurodegenerative diseases.